Cite
HARVARD Citation
Bird, N. et al. (2017). Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine‐based chemotherapy. British journal of surgery. 104 (4), pp. 328-336. [Online].